77 related articles for article (PubMed ID: 20153874)
21. Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population.
Chen Y; Chen X; Chen Q; Yu C
Front Endocrinol (Lausanne); 2021; 12():565714. PubMed ID: 33967948
[TBL] [Abstract][Full Text] [Related]
22. Nonfunctional adrenal adenomas and impaired glucose metabolism: a systematic review and meta-analysis.
Athanasouli F; Georgiopoulos G; Asonitis N; Petychaki F; Savelli A; Panou E; Angelousi A
Endocrine; 2021 Oct; 74(1):50-60. PubMed ID: 33963515
[TBL] [Abstract][Full Text] [Related]
23. Higher risk of chronic kidney disease and progressive kidney function impairment in primary aldosteronism than in essential hypertension. Case-control study.
Fernández-Argüeso M; Pascual-Corrales E; Bengoa Rojano N; García Cano A; Jiménez Mendiguchía L; Araujo-Castro M
Endocrine; 2021 Aug; 73(2):439-446. PubMed ID: 33797699
[TBL] [Abstract][Full Text] [Related]
24. Urine steroid profile as a new promising tool for the evaluation of adrenal tumors. Literature review.
Araujo-Castro M; Valderrábano P; Escobar-Morreale HF; Hanzu FA; Casals G
Endocrine; 2021 Apr; 72(1):40-48. PubMed ID: 33219921
[TBL] [Abstract][Full Text] [Related]
25. Association between Tumor Size and Malignancy Risk in Hormonally Inactive Adrenal Incidentalomas.
Vural V; Kılınç EM; Sarıdemir D; Gök İB; Hüseynov A; Akbarov A; Yaprak M
Cureus; 2020 Jan; 12(1):e6574. PubMed ID: 32051792
[TBL] [Abstract][Full Text] [Related]
26. Markers of Subclinical Cardiovascular Disease in Patients with Adrenal Incidentaloma.
Szychlińska M; Baranowska-Jurkun A; Matuszewski W; Wołos-Kłosowicz K; Bandurska-Stankiewicz E
Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32050625
[TBL] [Abstract][Full Text] [Related]
27. Nonfunctioning and Subclinical Cortisol Secreting Adrenal Incidentalomas and their Association with Metabolic Syndrome: A Systematic Review.
Khan U
Indian J Endocrinol Metab; 2019; 23(3):332-346. PubMed ID: 31641636
[TBL] [Abstract][Full Text] [Related]
28. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular Outcomes in Autonomous Cortisol Secretion and Nonfunctioning Adrenal Adenoma: A Systematic Review.
Park J; De Luca A; Dutton H; Malcolm JC; Doyle MA
J Endocr Soc; 2019 May; 3(5):996-1008. PubMed ID: 31065617
[TBL] [Abstract][Full Text] [Related]
30. The relationship between adrenal incidentalomas and mortality risk.
Taya M; Paroder V; Bellin E; Haramati LB
Eur Radiol; 2019 Nov; 29(11):6245-6255. PubMed ID: 30993434
[TBL] [Abstract][Full Text] [Related]
31. Surgery for adrenal angiomyelolipoma: an individualized concept.
Weber F; Shaibekov A; Nensa F; Zeng X; Dralle H
Langenbecks Arch Surg; 2019 Jun; 404(4):403-409. PubMed ID: 30972487
[TBL] [Abstract][Full Text] [Related]
32. Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with Updated Diagnostic Criteria for Sub-clinical Cushing's Syndrome.
Abe I; Sugimoto K; Miyajima T; Ide T; Minezaki M; Takeshita K; Takahara S; Nakagawa M; Fujimura Y; Kudo T; Miyajima S; Taira H; Ohe K; Ishii T; Yanase T; Kobayashi K
Intern Med; 2018 Sep; 57(17):2467-2472. PubMed ID: 29709936
[TBL] [Abstract][Full Text] [Related]
33. Does IGF-1 play a role in the etiopathogenesis of non-functioning adrenocortical adenoma?
Bahadir CT; Ecemis GC; Atmaca H
J Endocrinol Invest; 2018 Nov; 41(11):1317-1323. PubMed ID: 29542030
[TBL] [Abstract][Full Text] [Related]
34. The Role of Insulin Resistance/Hyperinsulinism on the Rising Trend of Thyroid and Adrenal Nodular Disease in the Current Environment.
Tsatsoulis A
J Clin Med; 2018 Feb; 7(3):. PubMed ID: 29495350
[TBL] [Abstract][Full Text] [Related]
35. The radiographically diagnosed adrenal myelolipoma: what do we really know?
Campbell MJ; Obasi M; Wu B; Corwin MT; Fananapazir G
Endocrine; 2017 Nov; 58(2):289-294. PubMed ID: 28866749
[TBL] [Abstract][Full Text] [Related]
36. The Relationship Between Increased Epicardial Fat Thickness and Left Ventricular Hypertrophy and Carotid Intima-Media Thickness in Patients With Nonfunctional Adrenal Incidentaloma.
Imga NN; Ucar Elalmis O; Muslum Tuna M; Aycıcek Dogan B; Sahin D; Berker D; Guler S
Int J Endocrinol Metab; 2016 Jul; 14(3):e37635. PubMed ID: 27942264
[TBL] [Abstract][Full Text] [Related]
37. "Nonfunctional" Adrenal Tumors and the Risk for Incident Diabetes and Cardiovascular Outcomes: A Cohort Study.
Lopez D; Luque-Fernandez MA; Steele A; Adler GK; Turchin A; Vaidya A
Ann Intern Med; 2016 Oct; 165(8):533-542. PubMed ID: 27479926
[TBL] [Abstract][Full Text] [Related]
38. Carotid Intima-Media Thickness as the Cardiometabolic Risk Indicator in Patients with Nonfunctional Adrenal Mass and Metabolic Syndrome Screening.
Evran M; Akkuş G; Berk Bozdoğan İ; Gök M; Deniz A; Sert M; Tetiker T
Med Sci Monit; 2016 Mar; 22():991-7. PubMed ID: 27015815
[TBL] [Abstract][Full Text] [Related]
39. Adrenal incidentaloma: Anesthetic management, the challenge and the outcome.
Al-Hadhrami RM; Gahndour N; Qudeera S; Moazin M; Nafakh R
Anesth Essays Res; 2011; 5(2):217-23. PubMed ID: 25885394
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of partial adrenalectomy for concomitant hypertension in patients with nonfunctional adrenal adenoma.
Xu T; Xia L; Wang X; Zhang X; Zhong S; Qin L; Zhang X; Zhu Y; Shen Z
Int Urol Nephrol; 2015 Jan; 47(1):59-67. PubMed ID: 25305227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
